Literature DB >> 6983563

Primary cell-mediated lympholysis response to a maternally transmitted antigen.

R Smith, D P Huston, R R Rich.   

Abstract

Mta-specific cytotoxic T lymphocyte (CTL) can be generated in primary cultures of (NZB X B10.D2)F1 spleen cells with H-2-compatible BALB/c stimulator cells. The CTL lyse reciprocal Mta+ (B10.D2 X NZB)F1 as well as H-2-disparate targets, such as B10, B6, and B6-Tlaa; they do not lyse targets from NZB or any F1 hybrid of an NZB mother. The lysis of 51Cr-labeled B10 targets is completely inhibited by unlabeled targets from Mta+ (B10.D2 X NZB)F1, but not from the reciprocal Mta- F1, thus demonstrating H-2-unrestricted lysis of Mta.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6983563      PMCID: PMC2186876          DOI: 10.1084/jem.156.6.1866

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  Patterns of immune reactivity in autoimmune murine strains. I. Cell-mediated immune responses induced by H-2 indentical and H-2 incompatible stimulator cells.

Authors:  A N Theofilopoulos; D L Shawler; D H Katz; F J Dixon
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

2.  H-2 unrestricted cytotoxic T cell activity against antigens controlled by genes in the QA/TLA region.

Authors:  J Forman
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

3.  Specificities of NZB anti-H-2d CML reactions: role of Qa-1 and retroviral gp70 antigens.

Authors:  A N Theofilopoulos; D L Shawler; R S Balderas; J H Elder; D H Katz; F J Dixon
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

4.  Qa-1-associated antigens. I. Generation of H-2-nonrestricted cytotoxic T lymphocytes specific for determinants of the Qa-1 region.

Authors:  D L Kastner; R R Rich; F W Shen
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

5.  Qed-1--a target for unrestricted killing by T cells.

Authors:  K F Lindahl; B Hausmann
Journal:  Eur J Immunol       Date:  1980-04       Impact factor: 5.532

6.  Primary in vitro cytotoxic response of NZB spleen cells to Qa-1b-associated antigenic determinants.

Authors:  R R Rich; D A Sedberry; D L Kastner; L Chu
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

7.  Maternally transmitted target antigen for unrestricted killing by NZB T lymphocytes.

Authors:  K Fischer Lindahl; M Bocchieri; R Riblet
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

8.  On the T cell hyperreactivity of NZB mice against H-2-identical cells. Evidence for primary response characteristics and an increased helper potential.

Authors:  B Stockinger; U Botzenhardt
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

9.  The major histocompatibility complex determines susceptibility to cytotoxic T cells directed against minor histocompatibility antigens.

Authors:  M J Bevan
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

10.  Primary in vitro cell-mediated lympholysis reaction of NZB mice against unmodified targets syngeneic at the major histocompatibility complex.

Authors:  U Botzenhardt; J Klein; M Ziff
Journal:  J Exp Med       Date:  1978-05-01       Impact factor: 14.307

View more
  3 in total

1.  Mitochondrial modulation of maternally transmitted antigen: analysis of cell hybrids.

Authors:  M M Huston; R Smith; R Hull; D P Huston; R R Rich
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  Differences in maternal lineages of New Zealand Black mice defined by restriction endonuclease analysis of mitochondrial DNA and by expression of maternally transmitted antigen.

Authors:  M M Huston; R Smith; D P Huston; R R Rich
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

3.  Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta.

Authors:  S M Shawar; R G Cook; J R Rodgers; R R Rich
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.